January 27th, 2007
Increased Chemotherapy Dose, Not Beneficial to Osteosarcoma Patients
Compared to standard doses of chemotherapy, a dose-intensive regimen of cisplatin and doxorubicin offered no clinical benefit in patients with the bone cancer osteosarcoma.
Such were the findings of a randomized clinical trial whose data has been reported in the January 17 issue of the Journal of the National Cancer Institute.
In other cancers such as non-Hodgkin […]
Recent Comments